How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer?

  title={How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer?},
  author={Ege Can Şerefoğlu and Serkan Altınova and Nevzat Serdar Uğraş and Egemen Akıncıoğlu and Erem Asil and Mevlana Derya Balbay},
  journal={Canadian Urological Association journal = Journal de l'Association des urologues du Canada},
  volume={7 5-6},
INTRODUCTION Prostate biopsies incur the risk of being false-negative and this risk has not yet been evaluated for 12-core prostate biopsy. We calculated the false-negative rate of 12-core prostate biopsy and determined the patient characteristics which might affect detection rate. METHODS We included 90 prostate cancer patients (mean age of 64, range: 49-77) diagnosed with transrectal ultrasound guided 12-core prostate biopsy between December 2005 and April 2008. All patients underwent… Expand
Detection of Significant Prostate Cancer According to Anatomical Areas of Sampling Cores Obtained with Transrectal Systematic 12-Core Biopsy
About half of the significant cancers were not accurately detected, and the detection rates in biopsy cores other than the sextant cores appeared to be significantly lower in PCa patients with aggressive features. Expand
Does the prostate volume always effect cancer detection rate in prostate biopsy? Additional role of prostate-specific antigen levels: A retrospective analysis of 2079 patients.
According to the findings, prostate volume is an important factor for prostate cancer diagnosed with prostate biopsy only in patients with a PSA level of ≤10 ng/mL. Expand
The detection and upgrade rates of prostate adenocarcinoma following transperineal template-guided prostate biopsy – a tertiary referral centre experience
Introduction We aim to present transperineal template-guided prostate biopsy (template biopsy) outcomes at a tertiary referral centre. Furthermore, to identify the detection rate of prostate cancerExpand
Prostate cancer detection rates of magnetic resonance imaging-guided prostate biopsy related to Prostate Imaging Reporting and Data System score
Magnetic resonance imaging-guided prostate biopsy has a high detection rate of prostate cancer in men with cancer-suspicious lesions on multiparametric magnetic resonance Imaging-prostate, and this rate increases with the Prostate Imaging Reporting and Data System score. Expand
Multiparametric MRI in Prostate Cancer
Prostate cancer (PCa) is the second most common cancer in men and an estimated 1.1 million men worldwide were diagnosed with prostate cancer in 2012 with almost 70% of the cases occurring in moreExpand
Increasing detection of significant prostate cancer in younger men – ten year trends in prostate cancer risk profile in the Mid-West of Ireland
Significant PCa detection increased across all age groups but recently, a younger patient profile was diagnosed with high-grade disease and paves the way for future research on early-onset PCa. Expand
Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy
Cognitive mpMRI guided transperineal target biopsies increase the detection rate of clinically significant prostate cancer after a previously negative biopsy, however, in a repeat prostate biopsy setting, it is recommended applying a cognitive targeted biopsy with the addition of a systematic biopsy. Expand
Are TRUS-guided prostate biopsies in clinical practice robust enough to make a correct assessment of the surgical strategy in prostatectomies? Poor correlation between preoperative prostate biopsies and postoperative specimens
The pre-operative biopsies in this setting rarely match the final prostate PAD results, and the most common deviations were in localization and in Gleason score, where the majority consisted of a higher Gle Mason score and/or tumour presence in a previously unknown location. Expand
Outcomes of combination MRI-targeted and transperineal template biopsy in restaging low-risk prostate cancer for active surveillance
A combination of MRI-targeted and template biopsy may optimally risk-classify “low-risk” patients diagnosed on initial conventional transrectal ultrasonography (TRUS) prostate biopsy. Expand
"In-bore" MRI prostate biopsy is a safe preoperative clinical tool to exclude significant prostate cancer in symptomatic patients with benign prostatic obstruction before transurethral laser enucleation.
  • A. Porreca, D. D'agostino, +7 authors M. Giampaoli
  • Medicine
  • Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
  • 2020
INTRODUCTION Purpose of our study was to investigate the role of a negative in-bore MRI-guided biopsy (MRI-GB) in comparison to a negative multiparametric prostate MRI (mpMRI) and a contextualExpand